Escitalopram vs Ipilimumab

Escitalopram vs Ipilimumab: Overview

This comparison examines the pharmacological differences between Escitalopram and Ipilimumab.

Mechanism of Action

Escitalopram: S-enantiomer of citalopram; selective serotonin reuptake inhibitor.

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Escitalopram — 27-32 hours; Ipilimumab — 14.7 days.

Chemical Properties

Molecular Formula: Escitalopram — C20H21FN2O.

Molecular Weight: Escitalopram — 324.3920 g/mol.

Type: Escitalopram — Small molecule; Ipilimumab — Antibody.